112 related articles for article (PubMed ID: 8957672)
1. Chimeric rhinoviruses as tools for vaccine development and characterization of protein epitopes.
Arnold GF; Resnick DA; Smith AD; Geisler SC; Holmes AK; Arnold E
Intervirology; 1996; 39(1-2):72-8. PubMed ID: 8957672
[TBL] [Abstract][Full Text] [Related]
2. Libraries of human rhinovirus-based HIV vaccines generated using random systematic mutagenesis.
Resnick DA; Smith AD; Zhang A; Geisler SC; Arnold E; Arnold GF
AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S47-52. PubMed ID: 7865333
[TBL] [Abstract][Full Text] [Related]
3. Human rhinovirus type 14:human immunodeficiency virus type 1 (HIV-1) V3 loop chimeras from a combinatorial library induce potent neutralizing antibody responses against HIV-1.
Smith AD; Geisler SC; Chen AA; Resnick DA; Roy BM; Lewi PJ; Arnold E; Arnold GF
J Virol; 1998 Jan; 72(1):651-9. PubMed ID: 9420270
[TBL] [Abstract][Full Text] [Related]
4. Chimeras from a human rhinovirus 14-human immunodeficiency virus type 1 (HIV-1) V3 loop seroprevalence library induce neutralizing responses against HIV-1.
Resnick DA; Smith AD; Gesiler SC; Zhang A; Arnold E; Arnold GF
J Virol; 1995 Apr; 69(4):2406-11. PubMed ID: 7884887
[TBL] [Abstract][Full Text] [Related]
5. Chimeric rhinoviruses displaying MPER epitopes elicit anti-HIV neutralizing responses.
Yi G; Lapelosa M; Bradley R; Mariano TM; Dietz DE; Hughes S; Wrin T; Petropoulos C; Gallicchio E; Levy RM; Arnold E; Arnold GF
PLoS One; 2013; 8(9):e72205. PubMed ID: 24039745
[TBL] [Abstract][Full Text] [Related]
6. Antigenic characteristics of rhinovirus chimeras designed in silico for enhanced presentation of HIV-1 gp41 epitopes [corrected].
Lapelosa M; Arnold GF; Gallicchio E; Arnold E; Levy RM
J Mol Biol; 2010 Apr; 397(3):752-66. PubMed ID: 20138057
[TBL] [Abstract][Full Text] [Related]
7. Use of random systematic mutagenesis to generate viable human rhinovirus 14 chimeras displaying human immunodeficiency virus type 1 V3 loop sequences.
Smith AD; Resnick DA; Zhang A; Geisler SC; Arnold E; Arnold GF
J Virol; 1994 Jan; 68(1):575-9. PubMed ID: 8254775
[TBL] [Abstract][Full Text] [Related]
8. Design and construction of rhinovirus chimeras incorporating immunogens from polio, influenza, and human immunodeficiency viruses.
Arnold GF; Resnick DA; Li Y; Zhang A; Smith AD; Geisler SC; Jacobo-Molina A; Lee W; Webster RG; Arnold E
Virology; 1994 Feb; 198(2):703-8. PubMed ID: 7507283
[TBL] [Abstract][Full Text] [Related]
9. A disulfide-bound HIV-1 V3 loop sequence on the surface of human rhinovirus 14 induces neutralizing responses against HIV-1.
Zhang A; Geisler SC; Smith AD; Resnick DA; Li ML; Wang CY; Looney DJ; Wong-Staal F; Arnold E; Arnold GF
Biol Chem; 1999 Mar; 380(3):365-74. PubMed ID: 10223339
[TBL] [Abstract][Full Text] [Related]
10. Protein engineering to create biologically active peptides: recombinant human rhinoviruses that display peptide sequences.
Smith AD; Arnold E; Arnold GF
Behring Inst Mitt; 1997 Feb; (98):229-39. PubMed ID: 9382744
[TBL] [Abstract][Full Text] [Related]
11. The development of cowpea mosaic virus as a potential source of novel vaccines.
Porta C; Spall VE; Lin T; Johnson JE; Lomonossoff GP
Intervirology; 1996; 39(1-2):79-84. PubMed ID: 8957673
[TBL] [Abstract][Full Text] [Related]
12. Expression of antigenic epitopes of porcine reproductive and respiratory syndrome virus (PRRSV) in a modified live-attenuated porcine circovirus type 2 (PCV2) vaccine virus (PCV1-2a) as a potential bivalent vaccine against both PCV2 and PRRSV.
Piñeyro PE; Kenney SP; Giménez-Lirola LG; Heffron CL; Matzinger SR; Opriessnig T; Meng XJ
Virus Res; 2015 Dec; 210():154-64. PubMed ID: 26239318
[TBL] [Abstract][Full Text] [Related]
13. Human Rhinovirus Presenting 4E10 Epitope of HIV-1 MPER Elicits Neutralizing Antibodies in Human ICAM-1 Transgenic Mice.
Yi G; Tu X; Bharaj P; Guo H; Zhang J; Shankar P; Manjunath N
Mol Ther; 2015 Oct; 23(10):1663-70. PubMed ID: 26061648
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the use of non-pathogenic porcine circovirus type 1 as a vaccine delivery virus vector to express antigenic epitopes of porcine reproductive and respiratory syndrome virus.
Piñeyro PE; Kenney SP; Giménez-Lirola LG; Opriessnig T; Tian D; Heffron CL; Meng XJ
Virus Res; 2016 Feb; 213():100-108. PubMed ID: 26555162
[TBL] [Abstract][Full Text] [Related]
15. Viremia and immunogenicity in nonhuman primates of a tetravalent yellow fever-dengue chimeric vaccine: genetic reconstructions, dose adjustment, and antibody responses against wild-type dengue virus isolates.
Guirakhoo F; Pugachev K; Arroyo J; Miller C; Zhang ZX; Weltzin R; Georgakopoulos K; Catalan J; Ocran S; Draper K; Monath TP
Virology; 2002 Jun; 298(1):146-59. PubMed ID: 12093182
[TBL] [Abstract][Full Text] [Related]
16. Crystal Structures of Yeast-Produced Enterovirus 71 and Enterovirus 71/Coxsackievirus A16 Chimeric Virus-Like Particles Provide the Structural Basis for Novel Vaccine Design against Hand-Foot-and-Mouth Disease.
Lyu K; He YL; Li HY; Chen R
J Virol; 2015 Jun; 89(12):6196-208. PubMed ID: 25833050
[TBL] [Abstract][Full Text] [Related]
17. Protective immune responses induced by the immunization of mice with a recombinant bacteriophage displaying an epitope of the human respiratory syncytial virus.
Bastien N; Trudel M; Simard C
Virology; 1997 Jul; 234(1):118-22. PubMed ID: 9234952
[TBL] [Abstract][Full Text] [Related]
18. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.
Kang CY; Luo L; Wainberg MA; Li Y
Biol Chem; 1999 Mar; 380(3):353-64. PubMed ID: 10223338
[TBL] [Abstract][Full Text] [Related]
19. Construction and characterization of a recombinant human adenovirus type 3 vector containing two foreign neutralizing epitopes in hexon.
Xue C; Tian X; Li X; Zhou Z; Su X; Zhou R
Virus Res; 2014 Apr; 183():67-74. PubMed ID: 24518297
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B surface antigen vector delivers protective cytotoxic T-lymphocyte responses to disease-relevant foreign epitopes.
Woo WP; Doan T; Herd KA; Netter HJ; Tindle RW
J Virol; 2006 Apr; 80(8):3975-84. PubMed ID: 16571814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
